Afeyan Noubar is of Moderna, Inc.. Currently has a direct ownership of 2.22 Million shares of MRNA, which is worth approximately $91.4 Million. The most recent transaction as insider was on Jun 22, 2022, when has been sold 10,000 shares (Common Stock) at a price of $127.69 per share, resulting in proceeds of $1,276,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.22M
0% 3M change
3.59% 12M change
Total Value Held $91.4 Million

AFEYAN NOUBAR Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2022
SELL
Open market or private sale
$1,276,900 $127.69 p/Share
10,000 Reduced 0.39%
2,527,209 Common Stock
Jun 08 2022
SELL
Open market or private sale
$1,474,700 $147.47 p/Share
10,000 Reduced 0.39%
2,537,209 Common Stock
Jun 01 2022
SELL
Open market or private sale
$1,463,100 $146.31 p/Share
10,000 Reduced 0.39%
2,547,209 Common Stock
May 25 2022
SELL
Open market or private sale
$1,308,000 $130.8 p/Share
10,000 Reduced 0.39%
2,557,209 Common Stock
May 18 2022
SELL
Open market or private sale
$1,383,800 $138.38 p/Share
10,000 Reduced 0.39%
2,567,209 Common Stock
May 11 2022
SELL
Open market or private sale
$1,307,400 $130.74 p/Share
10,000 Reduced 0.45%
2,229,673 Common Stock
Apr 28 2022
BUY
Exercise of conversion of derivative security
-
703 Added 0.03%
2,239,673 Common Stock

Also insider at

MCRB
Seres Therapeutics, Inc. Healthcare
RUBY
Rubius Therapeutics, Inc. Healthcare
EVLO
Evelo Biosciences, Inc. Healthcare
OMGA
Omega Therapeutics, Inc. Healthcare
AFEYAN NOUBAR

Afeyan Noubar

Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA